A widely sold pain-relieving ointment available at major U.S. retailers has been recalled after federal regulators determined its packaging fails to meet child-safety requirements, potentially putting young children at serious risk.
More than 50,000 containers of Mamisan Pain Relieving Topical Ointment are affected by the recall, which was announced after authorities found that the product’s jar can be opened too easily by children. The ointment contains lidocaine, a powerful topical anesthetic that can be dangerous—life-threatening—if swallowed by a child.
Why the Product Is Being Recalled
According to the U.S. Consumer Product Safety Commission (CPSC), the recall was triggered because the ointment is not packaged in a child-resistant container, as required by federal law.
Under the Poison Prevention Packaging Act, products containing lidocaine must be sold in packaging specifically designed to prevent young children from accessing the contents. Investigators found that the Mamisan ointment was sold with a standard screw-top lid that does not meet these safety standards.
The CPSC warned that the packaging “poses a risk of serious injury or death from poisoning if the contents are swallowed by young children.”
Where the Ointment Was Sold
The recalled ointment was sold nationwide at:
-
Walmart stores
-
Target stores
-
Online through Target.com
Sales took place between April 2024 and October 2025, with the product typically priced at around $10 per container.
Because of the broad distribution, regulators believe many of the recalled jars may still be stored in homes across the country, increasing the importance of consumer awareness.
What Makes Lidocaine Dangerous for Children
Lidocaine is commonly used to relieve pain by numbing tissue, but ingestion—especially by young children—can be extremely hazardous.
According to poison control experts, swallowing lidocaine can cause immediate numbness of the mouth and throat, which raises the risk of choking or airway obstruction. If enough lidocaine is absorbed into the bloodstream, it can interfere with the nervous system and heart.
Potential symptoms of lidocaine poisoning include:
-
Drowsiness and dizziness
-
Confusion or agitation
-
Headaches
-
Seizures
-
Loss of consciousness
-
Cardiac rhythm disturbances
-
Cardiac arrest in severe cases
Medical professionals emphasize that even small amounts can be dangerous for children due to their lower body weight and developing systems.
What Consumers Should Do Immediately
Regulators are urging consumers who have purchased the ointment to take action right away.
If you have this product in your home:
-
Stop using the product immediately.
-
Store it out of sight and reach of children until a replacement lid is received.
-
Do not leave the jar in easily accessible locations, such as bathroom counters, bedside tables, or medicine cabinets without child locks.
The distributor is offering a free child-resistant replacement lid to all customers who own the recalled product.
How to Get a Free Replacement Lid
Consumers can request a compliant child-resistant lid at no cost by contacting the distributor directly. Multiple contact options are available to make the process easy.
Customers may:
-
Call toll-free 855-752-6869 (Monday through Friday, 9 a.m. to 4 p.m. Pacific Time)
-
Email customercare@plantimexusa.com with the subject line “RECALL”
-
Visit the company’s official website for recall instructions
No proof of purchase is required to receive the replacement lid, according to recall details.
How to Identify the Recalled Product
Only specific jars of the ointment are included in the recall. Consumers should check their containers carefully.
The recalled product has the following characteristics:
-
Mamisan Pain Relieving Topical Ointment
-
3.52-ounce orange plastic jar
-
White screw-top lid
-
Mamisan branding on the lid and label
-
UPC code: 860006498115
If your jar matches this description, it is part of the recall.
Manufacturer and Distributor Details
The ointment was manufactured by MiramarLab, based in Doral, Florida, and distributed by Plantimex Distributors Inc., headquartered in San Diego, California.
The product was manufactured in the United States.
Officials stressed that the recall is focused on packaging compliance, not contamination or formulation errors. Still, the risk posed by improper packaging was considered serious enough to warrant immediate action.
No Injuries Reported—Yet
As of the recall announcement, no injuries or poisoning incidents involving the ointment had been officially reported. However, regulators emphasized that recalls are often issued before injuries occur, precisely to prevent worst-case scenarios.
Safety advocates say many poison-related injuries happen quietly inside homes and may go unreported, especially when parents are able to intervene quickly.
A Broader Reminder for Household Safety
This recall highlights a broader issue surrounding household medications and topical treatments that may seem harmless but contain powerful active ingredients.
Experts recommend that all households:
-
Store medications in locked or child-proof cabinets
-
Avoid transferring products to unmarked containers
-
Regularly check recall notices for consumer products
-
Educate caregivers and family members about poisoning risks
With millions of children treated in emergency rooms each year for accidental ingestions, regulators say preventive steps can save lives.
Final Word From Safety Officials
Federal safety officials stressed that consumers should take recalls seriously, even when no injuries have been reported.
“Child-resistant packaging exists for a reason,” regulators noted. “Swift action by consumers helps prevent injuries and saves lives.”
Anyone who suspects a child may have ingested lidocaine or any medication should contact poison control or seek emergency medical care immediately.
As recalls continue to affect everyday products sold at major retailers, officials urge consumers to stay alert—and to act quickly when safety warnings are issued.
Emily Johnson is a critically acclaimed essayist and novelist known for her thought-provoking works centered on feminism, women’s rights, and modern relationships. Born and raised in Portland, Oregon, Emily grew up with a deep love of books, often spending her afternoons at her local library. She went on to study literature and gender studies at UCLA, where she became deeply involved in activism and began publishing essays in campus journals. Her debut essay collection, Voices Unbound, struck a chord with readers nationwide for its fearless exploration of gender dynamics, identity, and the challenges faced by women in contemporary society. Emily later transitioned into fiction, writing novels that balance compelling storytelling with social commentary. Her protagonists are often strong, multidimensional women navigating love, ambition, and the struggles of everyday life, making her a favorite among readers who crave authentic, relatable narratives. Critics praise her ability to merge personal intimacy with universal themes. Off the page, Emily is an advocate for women in publishing, leading workshops that encourage young female writers to embrace their voices. She lives in Seattle with her partner and two rescue cats, where she continues to write, teach, and inspire a new generation of storytellers.
